eli lilly sues compounders for selling unapproved copies of tirzepatide compounding pharmacies over Mounjaro versions According to a criminal complaint,
Description
traceable batch information
Obtain a urine culture with antimicrobial susceptibility testing before initiating antibiotics, as this is essential for guiding definitive therapy and monit...
GLP-13/
Empower is a major 503A/503B compounder offering semaglutide and tirzepatide nationwide, but its record includes repeated FDA scrutiny.
Harvard geneticist David Sinclair reveals a rare but serious blindness risk linked to GLP-1 drugs, estimating 20,00030,000 NAION cases per year in
By analyzing more than four million venom peptides, researchers discovered new antimicrobial compounds that could transform the fight against deadly superbugs.
